Showing results (201-210 of 300) with videos related to

Sort By:
Pageof 30
Dalton Transactions (Cambridge, England : 2003)|February 19, 2020
Trinuclear ruthenium core-containing polyoxometalate-based hybrids: preparation, characterization and catalytic behaviorHuafeng Li, Peipei He, Rong Wan, et al.
Frontiers in Chemistry|March 8, 2021
A 3D Silverton-Type Polyoxomolybdate Based on {PrMo12O42}: Synthesis, Structure, Photoluminescence and Magnetic PropertiesYanxin Zhao, Xiaopeng Sun, Yanfang Ji, et al.
Chemical Communications (Cambridge, England)|August 17, 2022
An intriguing tetranuclear Rh-based polyoxometalate for the reduction of nitroarene and oxidation of anilineWenjing Chen, Huafeng Li, Yuzhen Jin, et al.
Inorganic Chemistry|August 4, 2022
2D Windmill-like Ln-Containing Organophosphonate-Based Polyoxomolybdates: Synthesis, Characterization, Fluorescence, and MagnetismSiyu Liu, Jiayu Liu, Haotian Guo, et al.
Chemical Communications (Cambridge, England)|September 16, 2021
A Rh-substituted polyoxometalate with an acetate-modified building block {As2W22O76(CH3COO)2}Zhen Liu, Xue Zhang, Rong Wan, et al.
Inorganic Chemistry|December 17, 2024
Ru Metalloligands Participate in the Construction of POM@MOF for Enhancing the Visible Photoinduced Baeyer-Villiger Oxidation ReactionLuoning Li, Yanan Liu, Jing Wang, et al.
Inorganic Chemistry|April 11, 2024
Intensifying Photocatalytic Baeyer-Villiger Oxidation of Ketones with the Introduction of Ru Metalloligands and Bimetallic Units in POM@MOFJing Wang, Luoning Li, Yanan Liu, et al.
Dalton Transactions (Cambridge, England : 2003)|March 1, 2024
Two binuclear Ni-inserted polyoxotantalates based on {NiTa10O32} units with catalytic activityHui Zhao, Hanhan Chen, Ming Yang Zhang, et al.
Transactions of the Royal Society of Tropical Medicine and Hygiene|March 27, 2021
Prevalence of viral hepatitis B and C in Sierra Leone-current knowledge and knowledge gaps: a narrative reviewSulaiman Lakoh, Noemí García-Tardón, Olukemi Adekanmbi, et al.
Frontiers in Pharmacology|October 3, 2022
Efficacy and safety of PD-1 and PD-L1 inhibitors combined with chemotherapy in randomized clinical trials among triple-negative breast cancerYihang Qi, Wenxiang Zhang, Ray Jiang, et al.
Pageof 30